Bexsero® (Meningococcal B) vaccine availability
02 November 2016
Recently there has been a global increase in demand for Bexsero® (meningococcal B) vaccine which is reflected in Australia as well.
Bexsero is a multi-component Meningococcal B vaccine and is not currently available on the National Immunisation Program.
The increasing demand for Bexsero across the world means that supply of the vaccine to Australia is constrained and will be unavailable until early 2017.
Please visit the TGA website for ongoing updates to supply.
We regret the inconvenience this may cause people and their families who want the vaccine, pharmacists and doctors.
For more information, please contact GSK medical information on 1800 033 109.
Bexsero Consumer Medicine Information
For media enquiries, please contact:
Kim O’Donohue - 0477 322 431, email@example.com